NRTSF — Nobilis Health Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $153.07m
- $299.72m
R2013 December 31st | R2014 December 31st | 2015 December 31st | 2016 December 31st | 2017 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS/A | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 31.1 | 84 | 229 | 286 | 300 |
Cost of Revenue | |||||
Gross Profit | 31.1 | — | — | — | — |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 18.7 | 63.5 | 196 | 276 | 277 |
Operating Profit | 12.4 | 20.5 | 33.4 | 10 | 22.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 7.22 | 16.4 | 40.7 | 11.6 | 23.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7.04 | 16 | 63.9 | 7.1 | 10.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1.57 | 2.89 | 50.8 | 6.45 | 3.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 1.57 | 2.89 | 50.8 | 6.45 | 3.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.021 | 0.061 | 0.661 | 0.083 | 0.049 |
Dividends per Share |